Log in to save to my catalogue

Patent Issued for Use of metformin and analogs thereof to reduce RAN protein levels in the treatment...

Patent Issued for Use of metformin and analogs thereof to reduce RAN protein levels in the treatment...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A785947243

Patent Issued for Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders (USPTO 11903910)

About this item

Full title

Patent Issued for Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders (USPTO 11903910)

Publisher

NewsRX LLC

Journal title

Mental Health Weekly Digest, 2024, p.1091

Language

English

Publication information

Publisher

NewsRX LLC

More information

Alternative Titles

Full title

Patent Issued for Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders (USPTO 11903910)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A785947243

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A785947243

Other Identifiers

ISSN

1543-6616

How to access this item